All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
TEVA total return snapshot: TEVA returned +88.67% over the past year and −1.28% YTD, with dividends reinvested. Since Feb. 16, 1982, TEVA is up +8,320.33% in nominal total return, or +10.49%/yr, and is currently −54.01% below its total-return high on Jul. 27, 2015.
Data ending Fri Jul. 24, 2026
| Tue 1982-02-16💬 to Fri 2026-07-24 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+8,320.33%
+10.49%/yr |
+13.57%/yr
R2=0.671 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16💬 to Fri 2026-07-24 |
Start
Value |
End
Value |
|---|---|---|
| TEVA × |
$10,000.00
1982-02-16 |
$842,033.34
2026-07-24 |
| YTD | YoY | |
|---|---|---|
| TEVA × | −1.28% | +88.67% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| TEVA × |
−54.01%
on 2026-07-24 from 2015-07-27 peak |
−93.11%
on 1984-11-19 |
| Period ending Fri 2026-07-24 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| TEVA × | +88.67% |
+86.73% +36.65%/yr |
+256.60% +52.78%/yr |
+249.72% +28.45%/yr |
−40.89% −5.12%/yr |
| Year | TEVA |
|---|---|
| 2026 (YTD) | −1.28% |
| 2025 | +41.61% |
| 2024 | +111.11% |
| 2023 | +14.47% |
| 2022 | +13.86% |
| 2021 | −16.99% |
| 2020 | −1.53% |
| 2019 | −36.45% |
| 2018 | −18.63% |
| 2017 | −45.96% |
| 2016 | −43.20% |
| 2015 | +16.71% |
| 2014 | +47.36% |
| 2013 | +10.91% |
| 2012 | −5.14% |
| 2011 | −21.04% |
| 2010 | −5.90% |
| 2009 | +33.62% |
| 2008 | −7.36% |
| 2007 | +50.98% |
| 2006 | −27.12% |
| 2005 | +45.25% |
| 2004 | +6.04% |
| 2003 | +47.90% |
| 2002 | +25.98% |
| 2001 | −15.50% |
| 2000 | +106.82% |
| 1999 | +77.01% |
| 1998 | −13.45% |
| 1997 | −5.42% |
| 1996 | +9.46% |
| 1995 | +94.21% |
| 1994 | −18.61% |
| 1993 | +38.40% |
| 1992 | +133.91% |
| 1991 | +65.73% |
| 1990 | −0.83% |
| 1989 | +73.43% |
| 1988 | +10.75% |
| 1987 | +0.31% |
| 1986 | +132.24% |
| 1985 | +210.19% |
| 1984 | −32.28% |
| 1983 | −73.44% |
| 1982 | −44.85% |
